There was a major breakthrough for scientists from Australia who designed a new blood test named “painHS” to detect chronic pain through color biomarkers.

Dr. Mark Hutchinson, the neuroscientist cum director of Australian Research Council Centre of Excellence for Nanoscale BioPhotonics at the University of Adelaide said, “This gives us a brand new window into patients’ pain because we have created a new tool that not only allows for greater certainty of diagnosis but also can guide better drug treatment options.”

Hutchinson literally quantified the color of pain in order to predict its severity. Persistent chronic pain was found to have a different natural color in immune cells. The research also suggested that the immune cells play a major role in controlling chronic pain sensations.

Hutchinson further added, “We now know there is a peripheral cell signal so we could start designing new types of drugs for new types of cellular therapies that target the peripheral immune system to tackle central nervous system pain.”

This painHS test work out very well in animals also. The research team believed that the cost effective “painHS” diagnosis test would reach all the physicians within 18 months to determine the severity of chronic pain such as migraines, lower back pain, fibromyalgia, pelvic pain and cancer pain.